Centre for Animal Biotechnology (CAB)
Overview
The Centre for Animal Biotechnology (CAB) is an international centre of excellence for basic and applied research in animal health and human disease models.
The major goals of CAB are to:
· Promote the use of appropriate animals as models for basic immune mechanisms and human diseases with an emphasis on large animals.
· Understand and develop ways of controlling infectious diseases including Helicobacter and Schistosoma.
· Conduct research into the immunology of veterinary species and encourage collaboration and scientific interchange between large animal researchers worldwide
· Disseminate research findings through public presentations and publication in international scientific journals.
· Effectively develop scientific discoveries into commercial opportunities, through developing strong links with commercial companies.
· Contribute to the training and mentoring of post-graduate students and post-doctoral researchers towards the development of independent researchers.
· Make a significant contribution to the positioning of the University of Melbourne as an international research-based university offering undergraduate and postgraduate education of the highest quality.
Number of employees
25
Specific focus of company
Animal Health, Vaccine Technology, Preclinical trials and target discovery.
Core Business Definition
Research and Development.
Competitive advantages
The CAB has extensive facilities and expertise for cellular immunology, protein chemistry and molecular biology in large animal species, especially sheep. This is complemented by state of the art animal house facilities and a fully equipped surgery.
CAB has established models for respiratory research including a unique sheep model for asthma.
Partners
Number of employees: 25
Main business focus/
Listing by sector:
- Immunology
- Biodiscovery
- Allergy & Respiratory
- Infectious Diseases
- Vaccines & Adjuvants
Competitive Advantages
The CAB has extensive facilities and expertise for cellular immunology, protein chemistry and molecular biology in large animal species, especially sheep. This is complemented by state of the art animal house facilities and a fully equipped surgery.
CAB has established models for respiratory research including a unique sheep model for asthma.
Technology/IP
Key research areas include:
- Allergy & Asthma
- Cellular Immunology
- Parasite Immunology
- Vaccine Development
- Identification of vaccine and diagnostic antigens
- Parasite vaccines
- Mucosal Immunization
- Single shot vaccines
- Ectoparasite control strategies
- Monoclonal antibody production
Partnering Opportunities
Contract and collaborative research opportunities exist in the field of: veterinary immunology, vaccine development, veterinary clinical and experimental trials, development of immunological assays, production of monoclonal antibodies, sheep models for respiratory diseases including asthma.
Partnering Needs
- Industry partners for linkage grants and contract research
- Joint venture partners for diagnostic development and target discovery
Contact Details
| Contact person | Dr. Jean-Pierre Scheerlink |
|---|---|
| Job Title | Director |
| Address | School of Veterinary Science, The University of Melbourne |
| City/Suburb | Parkville |
| State | Victoria |
| j.scheerlinck@unimelb.edu.au | |
| Phone | +61 3 8344 4441 |
| Fax | +61 3 8344 7374 |
| Website | http://www.cab.unimelb.edu.au |
